The XTT cell proliferation assay applied to cell layers embedded in three-dimensional matrix

Assay and Drug Development Technologies

Volumn 10, Issue 4, 2012, Pages 382-392

  Huyck, Lynn ^a,b   Ampe, Christophe ^a,b   Van Troys, Marleen ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS (2 METHOXY 4 NITRO 5 SULFOPHENYL) 2H TETRAZOLIUM 5 CARBOXANILIDE; CARBOXIN; COLLAGEN; MATRIGEL; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CELL INVASION; CELL PROLIFERATION; DRUG SENSITIVITY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MEASUREMENT; QUANTITATIVE ANALYSIS; XTT ASSAY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL COUNT; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; EXTRACELLULAR MATRIX; HUMANS; INDICATORS AND REAGENTS; KINETICS; MICROSCOPY, FLUORESCENCE; MICROSCOPY, PHASE-CONTRAST; NEOPLASM INVASIVENESS; NEOPLASMS; REPRODUCIBILITY OF RESULTS; TETRAZOLIUM SALTS;

EID: 84865460836     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2011.391     Document Type: Article

References (59)

1. Shum D, Radu C, Kim E, et al.: A high density assay format for the detection of novel cytotoxic agents in large chemical libraries. J Enzyme Inhib Med Chem 2008;23:931-945.
2. Tomelleri C, Dalla Pellegrina C, Chignola R: Microplate spectrophotometry for high-throughput screening of cytotoxic molecules. Cell Prolif 2010;43:130-138.
3. Slater K: Cytotoxicity tests for high-throughput drug discovery. Curr Opin Biotechnol 2001;12:70-74. (Pubitemid 32843147)
4. Carnero A: High throughput screening in drug discovery. Clin Transl Oncol 2006;8:482-490.
5. Justice BA, Badr NA, Felder RA: 3D cell culture opens new dimensions in cellbased assays. Drug Discov Today 2009;14:102-107.
6. Pathak A, Kumar S: Biophysical regulation of tumor cell invasion: moving beyond matrix stiffness. Integr Biol (Camb) 2011;3:267-278.
7. Bissell MJ, Radisky D: Putting tumours in context. Nat Rev Cancer 2001;1:46-54. (Pubitemid 33741880)
8. Abbott A: Cell culture: biology's new dimension. Nature 2003;424:870-872. (Pubitemid 37051657)
9. Hodkinson PS, Elliott T, Wong WS, et al.: ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrindependent activation of PI3-kinase. Cell Death Differ 2006;13:1776-1788. (Pubitemid 44390864)
10. Yamada KM, Cukierman E: Modeling tissue morphogenesis and cancer in 3D. Cell 2007;130:601-610. (Pubitemid 47268064)
11. Lee GY, Kenny PA, Lee EH, Bissell MJ: Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007;4:359-365. (Pubitemid 46766981)
12. Dhiman HK, Ray AR, Panda AK: Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. Biomaterials 2005;26:979-986. (Pubitemid 39213976)
13. Yoshii Y, Waki A, Yoshida K, et al.: The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and wellregulated spheroid formation. Biomaterials 2011;32:6052-6058.
14. Shen YH, Shoichet MS, Radisic M: Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater 2008;4:477-489.
15. Maltman DJ, Przyborski SA: Developments in three-dimensional cell culture technology aimed at improving the accuracy of in vitro analyses. Biochem Soc Trans 2010;38:1072-1075.
16. Tibbitt MW, Anseth KS: Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 2009;103:655-663.
17. Prestwich GD: Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. Acc Chem Res 2008;41:139-148.
18. Cukierman E, Bassi DE: Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors. Semin Cancer Biol 2010;20:139-145.
19. Wolf K, Alexander S, Schacht V, et al.: Collagen-based cell migration models in vitro and in vivo. Semin Cell Dev Biol 2009;20:931-941.
20. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. (Pubitemid 14203433)
21. Blaheta RA, Kronenberger B, Woitaschek D, et al.: Development of an ultrasensitive in vitro assay to monitor growth of primary cell cultures with reduced mitotic activity. J Immunol Methods 1998;211:159-169. (Pubitemid 28231074)
22. Jones LJ, Gray M, Yue ST, Haugland RP, Singer VL: Sensitive determination of cell number using the CyQUANT cell proliferation assay. J Immunol Methods 2001;254:85-98. (Pubitemid 32530750)
23. Sekhon BK, Roubin RH, Tan A, Chan WK, Sze DM: High-throughput screening platform for anticancer therapeutic drug cytotoxicity. Assay Drug Dev Technol 2008;6:711-721.
24. Quent VM, Loessner D, Friis T, Reichert JC, Hutmacher DW: Discrepancies between metabolic activity and DNA content as tool to assess cell proliferation in cancer research. J Cell Mol Med 2010;14:1003-1013.
25. Nociari MM, Shalev A, Benias P, Russo C: A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunol Methods 1998;213:157-167. (Pubitemid 28332808)
26. Scudiero DA, Shoemaker RH, Paull KD, et al.: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988;48:4827-4833.
27. Huertas D, Soler M, Moreto J, et al.: Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin. Oncogene 2012;31:1408-1418.
28. Jurado R, Lopez-Flores A, Alvarez A, Garcia-Lopez P: Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study. Oncol Rep 2009;22:1237-1245.
29. Mad'arova J, Lukesova M, Hlobilkova A, et al.: Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines. Mol Pathol 2002;55:227-234.
30. Nishimura M, Abiko Y, Mitamura J, Kaku T: Effect of cell plating density and extracellular matrix protein on cell growth of epithelial rests of Malassez in vitro. Med Electron Microsc 1999;32:127-132.
31. Ohbayashi M, Yasuda M, Kawakami I, Kohyama N, Kobayashi Y, Yamamoto T: Effect of interleukins response to ECM-induced acquisition of drug resistance in MCF-7 cells. Exp Oncol 2008;30:276-282.
32. Ranta V, Mikkola T, Ylikorkala O, Viinikka L, Orpana A: Reduced viability of human vascular endothelial cells cultured on Matrigel. J Cell Physiol 1998;176:92-98. (Pubitemid 28277199)
33. Miranda SC, Silva GA, Hell RC, Martins MD, Alves JB, Goes AM: Three-dimensional culture of rat BMMSCs in a porous chitosan-gelatin scaffold: A promising association for bone tissue engineering in oral reconstruction. Arch Oral Biol 2011;56:1-15.
34. Tang ZP, Liu N, Li ZW, et al.: In vitro evaluation of the compatibility of a novel collagen-heparan sulfate biological scaffold with olfactory ensheathing cells. Chin Med J (Engl) 2010;123:1299-1304.
35. Chiu LL, Weisel RD, Li RK, Radisic M: Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering. J Tissue Eng Regen Med 2011;5:69-84.
36. Zhang F, Xu R, Zhao MJ: QSG-7701 human hepatocytes form polarized acini in three-dimensional culture. J Cell Biochem 2010;110:1175-1186.
37. Oh SA, Lee HY, Lee JH, et al.: Collagen three-dimensional hydrogel matrix carrying basic fibroblast growth factor for the cultivation of mesenchymal stem cells and osteogenic differentiation. Tissue Eng Part A 2012;18:1087-1100.
38. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73. (Pubitemid 29278954)
39. Gough W, Hulkower KI, Lynch R, et al.: A quantitative, facile, and highthroughput image-based cell migration method is a robust alternative to the scratch assay. J Biomol Screen 2011;16:155-163.
40. Nizamutdinova IT, Kim YM, Chung JI, et al.: Anthocyanins from black soybean seed coats stimulate wound healing in fibroblasts and keratinocytes and prevent inflammation in endothelial cells. Food Chem Toxicol 2009;47:2806-2812.
41. Hulkower RL, Casanova LM, Rutala WA, Weber DJ, Sobsey MD: Inactivation of surrogate coronaviruses on hard surfaces by health care germicides. Am J Infect Control 2011;39:401-407.
42. Lim SO, Kim H, Jung G: p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma. FEBS Lett 2010;584:2231-2236.
43. Attoub S, Hassan AH, Vanhoecke B, et al.: Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol 2011;651:18-25.
44. Weaver VM, Petersen OW, Wang F, et al.: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997;137:231-245. (Pubitemid 27167310)
45. Alexa A, Varga J, Remenyi A: Scaffolds are active" regulators of signaling modules. FEBS J 2010;277:4376-4382.
46. Chen XD: Extracellular matrix provides an optimal niche for the maintenance and propagation of mesenchymal stem cells. Birth Defects Res C Embryo Today 2010;90:45-54.
47. Shih YR, Chen CN, Tsai SW, Wang YJ, Lee OK: Growth of mesenchymal stem cells on electrospun type I collagen nanofibers. Stem Cells 2006;24:2391-2397. (Pubitemid 44674298)
48. Santi DV, McHenry CS, Sommer H: Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 1974;13:471-481.
49. Ghoshal K, Jacob ST: An alternative molecular mechanism of action of 5fluorouracil, a potent anticancer drug. Biochem Pharmacol 1997;53:1569-1575. (Pubitemid 27356085)
50. Friedl P, Wolf K: Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2009;188:11-19.
51. Deacon SW, Beeser A, Fukui JA, et al.: An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chem Biol 2008;15:322-331. (Pubitemid 351508427)
52. Arias-Romero LE, Chernoff J: A tale of two Paks. Biol Cell 2008;100:97-108. (Pubitemid 351266767)
53. Molli PR, Li DQ, Murray BW, Rayala SK, Kumar R: PAK signaling in oncogenesis. Oncogene 2009;28:2545-2555.
54. Kim TY, Lee JW, Kim HP, Jong HS, Jung M, Bang YJ: DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma. Biochem Biophys Res Commun 2007;355:72-77. (Pubitemid 46273368)
55. Street CA, Bryan BA: Rho kinase proteins-pleiotropic modulators of cell survival and apoptosis. Anticancer Res 2011;31:3645-3657.
56. Zohrabian VM, Forzani B, Chau Z, Murali R, Jhanwar-Uniyal M: Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation. Anticancer Res 2009;29:119-123.
57. Provenzano PP, Keely PJ: Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J Cell Sci 2011;124(Pt 8):1195-1205.
58. Hakkinen KM, Harunaga JS, Doyle AD, Yamada KM: Direct comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of fibroblasts in four different three-dimensional extracellular matrices. Tissue Eng Part A 2011;17:713-724.
59. Woolfson DN, Mahmoud ZN: More than just bare scaffolds: towards multicomponent and decorated fibrous biomaterials. Chem Soc Rev 2010;39:3464-3479.